Insulin under normal circumstances exerts its antiatherogenic action in endothelial cells and VSMCs via the PI 3-kinase signaling pathway. Antiatherogenic aspects of insulin action include stimulation ...

A new study focuses on the insulin receptor to understand its role in the development of type 2 diabetes mellitus, a metabolic disease with a major impact on global health. Insulin resistance precedes ...

Researchers from the German Diabetes Center (DDZ) and the Heinrich Heine University Düsseldorf (HHU) have studied the temporal pattern of insulin action on protein kinases in human muscle cells in ...

Insulin resistance precedes and predicts the onset of type 2 diabetes mellitus (DM2), a chronic disease that causes high morbidity and mortality worldwide. In affected people, insulin is unable to ...

A clinical trial found that metformin, a drug typically used for type 2 diabetes, reduced insulin requirements by around 12% in adults with type 1 diabetes.

Researchers have discovered that the microbial metabolite TMA acts as a natural IRAK4 inhibitor, blocking inflammation and ...

Consequently, those with type 1 diabetes must administer insulin for the rest of their lives to regulate blood sugar levels.

The abstract will be published in the peer-reviewed Metabolism: Experimental and Clinical. The presentation will be available on Biomea Fusion's Investor Relations Page under the Events. Please find a ...

A cheap, century-old medication can improve life for people with type 1 diabetes, according to new research. A clinical trial in Australia found that type 2 diabetes drug metformin reduces insulin ...

Key Opinion Leader, Dr. Ralph DeFronzo presents the “Future of Menin Inhibitors” and discusses icovamenib and its clinical results shared during ...